Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
August 30, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
All Press Releases for January 3, 2006 Subscribe to this News Feed      
 

Terminated Pfizer Exec Nominated “Whiny Whistleblower of the Year” by Drug Industry Organization

The American Council on Science and Health on December 30, 2005 announced that they had nominated former Pfizer Vice President Peter Rost, M.D., to “Whiny Whistleblower of the Year.”

Short Hills, NJ (PRWEB) January 3, 2006 -- The American Council on Science and Health on December 30, 2005 announced that they had nominated former Pfizer Vice President Peter Rost, M.D., to “Whiny Whistleblower of the Year.”

Dr. Rost has been an outspoken advocate for drug re-importation and was terminated by Pfizer on December 1, 2005.

In his nomination, Gilbert Ross, M.D., Executive and Medical Director of the ACSH stated that the biggest “Whiny Whistleblower” for 2005 was “the person who most outrageously defied his or her employer, regardless of loyalty, science, or even common sense.” Dr. Ross concluded “I vote for ex-Pfizer V.P. Dr. Peter Rost, an inept exec but a pretty good whistleblower. He provoked a federal investigation of his own company in 2003, alleging that Pfizer was responsible for the improper marketing of the synthetic growth hormone Genotropin.”
http://www.acsh.org/factsfears/newsID.680/news_detail.asp

Dr. Rost responds, “To be officially nominated ‘Whiny Whistleblower of the Year’ by a front organization paid by Pfizer and Big Pharma is a great honor, even more so since I apparently competed against two real consumer heroes; Dr. David Graham, FDA, and Dr. Eric Topol, the Cleveland Clinic. I’m only saddened that Dr. Ross failed to mention that under my leadership Genotropin became the #1 performing +$100 million Pfizer franchise vs. budget in 2003.” Dr. Rost added, “I also note that perhaps Dr. Ross isn’t a good judge of character.” According to the magazine Mother Jones, “Ross spent all of 1996 at a federal prison camp in Schuylkill, Pennsylvania, having being sentenced to 46 months in prison for his participation in a scheme that ultimately defrauded New York's Medicaid program of approximately $8 million.”
http://www.motherjones.com/news/outfront/2005/11/paging_dr_ross.html

The American Council on Science and Health stopped disclosing corporate donors in the early 1990s, according to Integrity in Science. The following drug companies contributed to ACSH, according to ACSH’s 1991 annual report and ACSH Corporate Donors 1997: Pfizer, Abbott Laboratories, American Cyanamid, Bristol-Myers Squibb, Ciba-Geigy, Eli Lilly, Hoffman-La Roche, Johnson & Johnson, Rhone-Poulenc, Sandoz, Searle, Syntex, Warner-Lambert, Upjohn, Pharmaceutical Manufacturers Association.
http://www.cspinet.org/integrity/nonprofits/american_council_on_science_and_health.html

###

Other Releases by this Member
OPTIONS
Printer Friendly Version
Email this story to a colleague
CONTACT INFORMATION
Peter Rost
973 273 4668
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your login.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright